Vebreltinib Enteric Capsules

DRUG2 trials

Sponsors

Tianjin Medical University Second Hospital, Fudan University

Conditions

NSCLCNeoadjuvant TherapyPrecision MedicineSolid Tumor

Phase 2

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

RecruitingNCT06739395

Tianjin Medical University Second HospitalPrecision Medicine, Solid Tumor

Start: 2024-11-01End: 2027-05-01Target: 300Updated: 2024-12-18

Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

Not yet recruitingNCT07156604

Fudan UniversityNeoadjuvant Therapy, NSCLC

Start: 2025-09-30End: 2030-09-30Target: 30Updated: 2025-09-05